[1] Lopman BA, Steele D, Kirkwood CD, Parashar UD. The vast and varied global burden of norovirus: prospects for prevention and control. PLoS Med 2016;13(4):e1001999. http://dx.doi.org/10.1371/journal.pmed.1001999CrossRef
[2] Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am 2006;35(2):275 − 90. http://dx.doi.org/10.1016/j.gtc.2006.03.001CrossRef
[3] Martella V, Medici MC, De Grazia S, Tummolo F, Calderaro A, Bonura F, et al. Evidence for recombination between pandemic GII.4 norovirus strains New Orleans 2009 and Sydney 2012. J Clin Microbiol 2013;51(11):3855−7. http://dx.doi.org/10.1128/JCM.01847-13.http://dx.doi.org/10.1128/JCM.01847-13
[4] Lindesmith LC, Donaldson EF, Baric RS. Norovirus GII.4 strain antigenic variation. J Virol 2011;85(1):231 − 42. http://dx.doi.org/10.1128/JVI.01364-10CrossRef
[5] Cannon JL, Barclay L, Collins NR, Wikswo ME, Castro CJ, Magaña LC, et al. Genetic and epidemiologic trends of norovirus outbreaks in the United States from 2013 to 2016 demonstrated emergence of novel GII.4 recombinant viruses. J Clin Microbiol 2017;55(7):2208 − 21. http://dx.doi.org/10.1128/JCM.00455-17CrossRef
[6] He YQ, Jin M, Chen KN, Zhang HL, Yang H, Zhuo F, et al. Gastroenteritis outbreaks associated with the emergence of the new GII.4 Sydney norovirus variant during the epidemic of 2012/13 in Shenzhen city, China. PLoS One 2016;11(11):e0165880. http://dx.doi.org/10.1371/journal.pone.0165880.http://dx.doi.org/10.1371/journal.pone.0165880
[7] Jin M, Zhou YK, Xie HP, Fu JG, He YQ, Zhang S, et al. Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China. J Gen Virol 2016;97(10):2620 − 32. http://dx.doi.org/10.1099/jgv.0.000582CrossRef
[8] Jin M, Wu SY, Kong XY, Xie HP, Fu JG, He YQ, et al. Norovirus outbreak surveillance, China, 2016-2018. Emerg Infect Dis 2020;26(3):437 − 45. http://dx.doi.org/10.3201/eid2603.191183CrossRef
[9] Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinjé J. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol 2014;52(1):147 − 55. http://dx.doi.org/10.1128/JCM.02680-13CrossRef
[10] Thongprachum A, Khamrin P, Maneekarn N, Hayakawa S, Ushijima H. Epidemiology of gastroenteritis viruses in Japan: prevalence, seasonality, and outbreak. J Med Virol 2016;88(4):551 − 70. http://dx.doi.org/10.1002/jmv.24387CrossRef
[11] Cho HW, Chu C. Norovirus outbreaks occurred in different settings in the Republic of Korea. Osong Public Health Res Perspect 2015;6(5):281 − 2. http://dx.doi.org/10.1016/j.phrp.2015.11.001CrossRef
[12] Bureau of Disease Prevention and Control, National Health Commission of the People's Republic of China. Criterion for reporting infectious diseases in schools and child-care institutions (for trial implementation). http://www.nhc.gov.cn/zhjcj/s9139/200804/b7fc75fdc7ee43afaadc76803dbbbaff.shtml. [2007-3-5]. (In Chinese). http://www.nhc.gov.cn/zhjcj/s9139/200804/b7fc75fdc7ee43afaadc76803dbbbaff.shtml
[13] Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, Kapikian AZ, et al. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 2009;83(22):11890 − 901. http://dx.doi.org/10.1128/JVI.00864-09CrossRef
[14] Bull RA, Eden JS, Rawlinson WD, White PA. Rapid evolution of pandemic noroviruses of the GII. 4 lineage. PLoS Pathog 2010;6(3):e1000831. http://dx.doi.org/10.1371/journal.ppat.1000831CrossRef
[15] Ozaki K, Matsushima Y, Nagasawa K, Motoya T, Ryo A, Kuroda M, et al. Molecular evolutionary analyses of the RNA-dependent RNA polymerase region in norovirus genogroup II. Front Microbiol 2018;9:3070. http://dx.doi.org/10.3389/fmicb.2018.03070CrossRef